# Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

> **NCT04937283** · NA · RECRUITING · sponsor: **Shanghai Pulmonary Hospital, Shanghai, China** · enrollment: 690 (estimated)

## Conditions studied

- Lung Adenocarcinoma

## Interventions

- **PROCEDURE:** Segmentectomy
- **PROCEDURE:** Lobectomy

## Key facts

- **NCT ID:** NCT04937283
- **Lead sponsor:** Shanghai Pulmonary Hospital, Shanghai, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-10-01
- **Primary completion:** 2028-12-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 690 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04937283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04937283, "Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04937283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*